Arovella Therapeutics Limited's market cap is currently AU$110.13M. The company's EPS TTM is AU$-0.006; its P/E ratio is ―; Arovella Therapeutics Limited is scheduled to report earnings on August 27, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in AUD
Arovella Therapeutics Limited Earnings and Revenue History
